Related references
Note: Only part of the references are listed.Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum
Alfred Mahr et al.
RHEUMATOLOGY (2019)
Treatment Strategies in ANCA-Associated Vasculitis
Nkechinyere Emejuaiwe
CURRENT RHEUMATOLOGY REPORTS (2019)
Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
Fiona A. Pearce et al.
RHEUMATOLOGY (2017)
Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study
Cui Li et al.
BMJ OPEN (2017)
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type
Sebastian Unizony et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis
Shivani Shah et al.
CLINICAL RHEUMATOLOGY (2016)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
M. Yates et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients
Divi Cornec et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center
Jan H. Schirmer et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's) Distinct Patient Subsets
Eli M. Miloslavsky et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management
Matthieu Groh et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)
Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis
Kim M. O'Sullivan et al.
KIDNEY INTERNATIONAL (2015)
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Richard A. Watts et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure
Corinna Glasner et al.
SCIENTIFIC REPORTS (2015)
Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study
Satoshi Ikeda et al.
BMC PULMONARY MEDICINE (2015)
Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan
Nobuyuki Ono et al.
RHEUMATOLOGY INTERNATIONAL (2015)
A Population-based Study Showing Better Renal Prognosis for Proteinase 3 Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis Versus Myeloperoxidase ANCA-associated Nephritis
Aladdin J. Mohammad et al.
JOURNAL OF RHEUMATOLOGY (2014)
ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease
Masanori Murakami et al.
Modern Rheumatology (2014)
Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis A Series of 49 Patients and Review of the Literature
Cloe Comarmond et al.
MEDICINE (2014)
Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study
Ken-ei Sada et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
Alfred Mahr et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
E. M. Miloslavsky et al.
ARTHRITIS AND RHEUMATISM (2013)
Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis
Anoek A. E. de Joode et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis
Sophia Lionaki et al.
ARTHRITIS AND RHEUMATISM (2012)
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
EULAR recommendations for the management of primary small and medium vessel vasculitis
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Dual ANCA positivity in subacute bacterial endocarditis
Alexandra M. Tiliakos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies
M Chen et al.
KIDNEY INTERNATIONAL (2005)
Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000:: A capture-recapture estimate
A Mahr et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis
H Brockmann et al.
ARTHRITIS RESEARCH (2002)
Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis
A Schwarting et al.
KIDNEY INTERNATIONAL (2000)